Department of Medicine, Mayo Clinic, Rochester, USA.
Department of Medicine, Universidad Peruana Cayetano Heredia, Lima, USA.
BMJ Open. 2017 Aug 21;7(8):e016506. doi: 10.1136/bmjopen-2017-016506.
In the care of patients with type 2 diabetes, self-management is emphasised and studied while theory and observations suggest that patients also benefit from social support. We sought to assess the effect of social network interventions on social support, glycaemic control and quality of life in patients with type 2 diabetes.
We searched Ovid MEDLINE, Ovid EBM Reviews, Cochrane Central Register of Controlled Trials, EMBASE, PsycINFO and CINAHL through April 2017 for randomised clinical trials (RCTs) of social network interventions in patients with type 2 diabetes. Reviewers working independently and in duplicate assessed eligibility and risk of bias, and extracted data from eligible RCTs. We pooled estimates using inverse variance random effects meta-analysis.
We found 19 eligible RCTs enrolling 2319 participants. Social network interventions were commonly based on individual behaviour change rather than social or interpersonal theories of self-management, were educational, and sought to engage social network members for their knowledge and experience. Interventions improved social support (0.74 SD (95% CI 0.32 to 1.15), I=89%, 8 RCTs) and haemoglobin A1c at 3 months (-0.25 percentage points (95% CI -0.40 to -0.11), I=12%, 9 RCTs), but not quality of life.
Despite a compelling theoretical base, researchers have only minimally studied the value of interventions targeting patients' social networks on diabetes care. Although the body of evidence to date is limited, and based on individual behaviour change theories, the results are promising. This review challenges the scientific community to design and test theory-based interventions that go beyond self-management approaches to focus on the largely untapped potential of social networks to improve diabetes care.
CRD42016036117.
在 2 型糖尿病患者的护理中,强调并研究了自我管理,而理论和观察表明,患者也受益于社会支持。我们旨在评估社交网络干预对 2 型糖尿病患者的社会支持、血糖控制和生活质量的影响。
我们通过 Ovid MEDLINE、Ovid EBM Reviews、Cochrane 中央对照试验注册库、EMBASE、PsycINFO 和 CINAHL 检索了截至 2017 年 4 月的 2 型糖尿病患者社交网络干预的随机临床试验 (RCT),检索词包括“type 2 diabetes”、“randomized clinical trial”、“social network intervention”等。审查员独立并重复评估合格性和偏倚风险,并从合格的 RCT 中提取数据。我们使用逆方差随机效应荟萃分析来汇总估计值。
我们发现了 19 项符合条件的 RCT,共纳入了 2319 名参与者。社交网络干预通常基于个体行为改变,而不是自我管理的社会或人际理论,是教育性的,旨在利用社交网络成员的知识和经验。干预措施改善了社会支持 (0.74 SD (95%CI 0.32 至 1.15),I=89%,8 项 RCT) 和血红蛋白 A1c 在 3 个月时 (-0.25 个百分点 (95%CI -0.40 至 -0.11),I=12%,9 项 RCT),但对生活质量没有影响。
尽管有令人信服的理论基础,但研究人员对针对糖尿病患者社交网络的干预措施在糖尿病护理方面的价值的研究很少。尽管迄今为止的证据有限,而且基于个体行为改变理论,但结果是有希望的。这项综述挑战科学界设计和测试基于理论的干预措施,超越自我管理方法,关注社交网络在改善糖尿病护理方面的巨大潜力。
PROSPERO 注册号:CRD42016036117。